"Designing Growth Strategies is in our DNA"

Stomach Cancer/Gastric Cancer Treatment Market Size, Share & Industry Analysis, By Drug Type (Programmed Cell Death Protein 1 (PD-1) Inhibitors, Human Epidermal Growth Factor Receptor (HER2) Antagonists, and Others), By Disease Indication (Gastric Adenocarcinoma, Gastrointestinal Stromal Tumor (GIST)), By Route of Administration (Oral and Parenteral) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) and Regional Forecast, 2019-2026

The global stomach cancer/gastric cancer treatment market size stood at USD 2.61 billion in 2018 and is projected to reach USD 8.20 billion by 2026, exhibiting a CAGR of ... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : Global | Published Date: Feb, 2020 | Report ID: FBI102094 | Status : Published

 

Request a Sample

Refresh Button
Stomach-Gastric- Cancer- Treatment Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2018
  • 2015-2017
  • 130
  • Direct Purchase
  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X